Search
Search
Close this search box.

American Green and Curaleaf enter five-year grow management contract

American Green has entered into a new, five-year management services agreement with Curaleaf Holdings.

America’s second publicly-traded company in the cannabis sector, American Green, and international cannabis product provider for medical and adult-use, Curaleaf, have entered into the agreement for two of Curaleaf’s cultivation facilities in Arizona. 

Premium products

American Green’s premium cannabis is used in various Curaleaf and Select products, including some of their Live Resin offerings. The agreement will give American Green approximately (USD)$2.1m dollars in annual revenue and $10.4m in revenue over the term of the agreement.

Steve Cottrell, president of Curaleaf Arizona, said: “American Green has been a great partner to us and we are looking forward to continuing our relationship with them over the next five years.”

American Green president, David Gwyther, added: “We are proud to extend our relationship with Curaleaf Holdings, Inc. for five years. There is also an opportunity for American Green to continue the agreement for three additional five-year periods after our initial five-year term is up.  We will continue to provide our premium cannabis grown at our “Sweet Virginia” grow and provide the quality customer service that Curaleaf has been accustomed to so we can earn those future agreement extensions.”

American Green, which has a team of professionals in cultivation management, manufacturing, extraction, wholesale, retail, and community outreach, now has more than 50,000 certified beneficial shareholders, and aims to lead the cannabis and premium CBD industry.

[activecampaign form=31]

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?